StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.64−0.00 (-0.28%)

Close on Nov 17, 2026Market cap $1.96MP/E –Yield –

DataMeds AI r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for DataMeds AI

DataMeds AI has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More DataMeds AI figures

See a number that looks wrong?